Drug Delivery
Drug delivery systems include inhalers, injectors and infusion pumps; it is a sector of the pharmaceutical industry with tremendous growth prospects.
Browse Research and Markets’ Drug Delivery category to explore all aspects of this technology-driven industry, whether according to method of delivery (e.g. oral, intranasal, transdermal), affliction (e.g. diabetes, allergies, inflammation), or specific areas such as paediatric drug delivery, self-administration and drug safety.
Our
reports, books and subscription cover every conceivable aspect of this industry, including the latest industry activity in specific countries and regions (North America, Europe, Asia, etc.) and key information on leading players such as Valeant Pharmaceuticals, Elan Corporation, PetMed Express, Hospira, and many more.
Show Less
Read more
Update on Polymers for Ocular Drug Delivery
The eye is the most easily accessible site for topical administration of a medication Drugs are commonly applied to the eye for localised action on the surface or in the interior of the eye A major...
December
2011
EUR 95USD 124GBP 80AUD 132JPY 12,155SEK 822CHF 117CAD 129
Smart Infusion Pumps: Products, Markets, Players and Prospects
Smart Infusion Pumps: Products, Markets, Players and Prospects is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving...
November
2011
FROM
EUR 2,945USD 3,850GBP 2,482AUD 4,097JPY 377,051SEK 25 493CHF 3'623CAD 4,003
Drug Repositioning: New Technologies, Business Models & Strategies for Successful Development
Drug repositioning offers the possibility of breathing new life into pharmaceutical R&D By recycling drug data, repositioning promises to boost production, accelerate and derisk R&D, and enhance product...
October
2011
FROM
EUR 1,874USD 2,450GBP 1,579AUD 2,607JPY 239,942SEK 16 223CHF 2'305CAD 2,548
Special Report: The Autoimmune Biologics Pipeline-A Competitive Review
Although biologics such as the tumor necrosis factor-alpha (TNF-alpha) inhibitors have vastly improved the treatment of various autoimmune disorders, many patients are refractory to these and other...
August
2011
FROM
EUR 3,518USD 4,600GBP 2,965AUD 4,895JPY 450,503SEK 30 460CHF 4'328CAD 4,783
Next Generation Transdermal Drug Patches: Evolving Technology, Emerging Opportunities
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver Advances in synthetic materials...
August
2011
EUR 2,180USD 2,850GBP 1,837AUD 3,033JPY 279,116SEK 18 872CHF 2'682CAD 2,963
Hospital Injectable Drugs: Future Prospects for Generics & Biosimilars
The generic injectables sector exceeds US$11 2 billion and numerous high-value injectable products will face patent expiry in major markets over the next decade This critical new report evaluates the...
July
2011
FROM
EUR 1,620USD 2,118GBP 1,365AUD 2,254JPY 207,427SEK 14 025CHF 1'993CAD 2,202
Drug Delivery Innovations Driving Improved Patient Compliance
This report gives in depth coverage of the factors driving patient non compliance The report then goes on to describe and analyse key technologies being developed to improve compliance in the oral and...
July
2011
FROM
EUR 2,933USD 3,835GBP 2,472AUD 4,081JPY 375,582SEK 25 394CHF 3'609CAD 3,988
Combination Devices - Application Landscape
Medical Device Application Landscape Influenced by the Adoption of Emerging Drug-Device Combinations Manufacturers to Collaborate with Large Healthcare Companies to Commercialize Their Devices Minimally...
June
2011
FROM
EUR 4,972USD 6,500GBP 4,190AUD 6,917JPY 636,580SEK 43 041CHF 6'116CAD 6,759
Next Generation Sequencing: Opportunities, Trends and World Market
This report is about the fast-growing worldwide market for next-generation sequencing (NGS) tools and services NGS systems makers are effectively driving down the cost of sequencing a human genome Once...
May
2011
FROM
EUR 1,985USD 2,595GBP 1,673AUD 2,761JPY 254,142SEK 17 183CHF 2'442CAD 2,698
Iontophoresis Drug Delivery: Devices, Drugs and Therapeutic Prospects
To expand the limits of transdermal drug delivery, developers are employing energy sources such as ultrasound, heat and electrical current to affect active transport through the skin These techniques...
May
2011
FROM
EUR 2,180USD 2,850GBP 1,837AUD 3,033JPY 279,116SEK 18 872CHF 2'682CAD 2,963
Inhaled Pain Management: Products, Therapeutics, Markets and Forecasts
As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain...
May
2011
FROM
EUR 2,180USD 2,850GBP 1,837AUD 3,033JPY 279,116SEK 18 872CHF 2'682CAD 2,963
Transmucosal Drug Delivery. Markets & Prospects for Films, Sprays, Lozenges, Wafers & Tablets
In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a...
May
2011
FROM
EUR 2,945USD 3,850GBP 2,482AUD 4,097JPY 377,051SEK 25 493CHF 3'623CAD 4,003
Clinical Research Manual
A practical, annually updated international handbook for all those working in clinical research The editors have a wealth of experience between them of the teaching and practice of clinical research,...
May
2011
EUR 83USD 109GBP 70AUD 116JPY 10,636SEK 719CHF 102CAD 113
Transmucosal Drug Delivery: Markets & Prospects for Films, Sprays, Lozenges, Wafers & Tablets
‘Transmucosal Drug Delivery: Markets & Prospects for Films, Sprays, Lozenges, Wafers & Tablets’ is a comprehensive evaluation and analysis of the technology, products and participants behind the development...
May
2011
FROM
EUR 2,945USD 3,850GBP 2,482AUD 4,097JPY 377,051SEK 25 493CHF 3'623CAD 4,003
Western European Insulin Delivery Devices Market
This research service looks at the insulin delivery devices market in western Europe, covering the United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia The segments covered are insulin...
April
2011
FROM
EUR 4,972USD 6,500GBP 4,190AUD 6,917JPY 636,580SEK 43 041CHF 6'116CAD 6,759
8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
The 2011 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current...
April
2011
FROM
EUR 646USD 845GBP 545AUD 899JPY 82,755SEK 5 595CHF 795CAD 879
Insulin Delivery Systems Market Analysis (2008-2012)
Estimations suggesting that there will be 438 Million diabetic people in 2030 have alarmed the global community With such high expected rates of growth in the diabetic population, the demand for diabetes...
February
2011
FROM
EUR 918USD 1,200GBP 773AUD 1,277JPY 117,522SEK 7 946CHF 1'129CAD 1,248
STUDY GOALS AND OBJECTIVES: - To define and measure drug delivery market and its various sub-segments with respect to types of systems, by mode of drug delivery, by therapeutics and others - To identify...
February
2011
FROM
EUR 3,557USD 4,650GBP 2,997AUD 4,948JPY 455,399SEK 30 791CHF 4'375CAD 4,835
The Top 30 Transmucosal Drug Delivery Technology Companies Worldwide
Transmucosal routes of drug delivery (i e , the mucosal linings of the nasal, rectal, vaginal, ocular, and oral cavity) are well established For example, the oral transmucosal route has been used for...
February
2011
FROM
EUR 210USD 275GBP 177AUD 292JPY 26,889SEK 1 818CHF 258CAD 285
KEY TAKE AWAYS: - To define and measure the Injectable drug delivery market and its various sub-segments with respect to types of systems, by mode of drug delivery, by therapeutics, by re-usability...
February
2011
FROM
EUR 3,557USD 4,650GBP 2,997AUD 4,948JPY 455,399SEK 30 791CHF 4'375CAD 4,835
